Status:
COMPLETED
Study of the Effect of Glutamine Supplementation on Chemotherapy Induced Toxicities in Breast Cancer Patients
Lead Sponsor:
Banaras Hindu University
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-85 years
Phase:
PHASE4
Brief Summary
Glutamine, a non essential branched chain amino acid, is most important non toxic nitrogen carrier in body. It participates in variety of physiological functions. It is a major fuel source of enterocy...
Eligibility Criteria
Inclusion
- The patients \> 18 years of age
- Histologically or cytologically proven breast cancer
- Receiving CEF chemotherapy cycles presently or in the past
- The patients who will give informed consent to participate in the study
- Patients must have sufficient organ and marrow function
- Stage 1 neuropathy, subclinical neuropathy, surgery induced neuropathy
Exclusion
- Pregnancy
- Clinical/biochemical severe liver failure
- Clinical/biochemical severe renal dysfunction
- Refusal to participate in the study
- Patients who have received prior chemotherapy with paclitaxel.
- Patients who have neuropathy due to any known systemic or metabolic causes like diabetes, leprosy, nutritional deficiency induced (vit. B12) etc
Key Trial Info
Start Date :
December 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT00772824
Start Date
December 1 2007
End Date
December 1 2009
Last Update
July 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sir Sunder Lal Hospital
Varanasi, Uttar Pradesh, India, 221005